Combination phentermine and topiramate extended release in the management of obesity
Summary: Follow all dosing directions and call your provider if unsure
With semaglutide no longer in shortage, Novo says compounded versions are not justified
Blood pressure may begin to decrease in hypertensive patients, and a small increase in heart rate is common
Potential future treatments for CKD in type 1 diabetes Beyond the classes of medication discussed above, additional pharmacological treatments are being investigated for use in DKD that may be suitable for use in type 1 diabetes
A sensitivity analysis accounting for factors such as demographics, starting BMI classification, residence in a socially vulnerable area, comorbidities, and baseline HbA1c level also found that patients on GLP-1s were more likely to experience weight loss and to reduce their HbA1c levels